This finding may be explained that patients with squamous cell carcinoma, adenosquamous carcinoma, or other histological types of lung cancer sometimes have complex somatic mutations driving treatment resistance when compared with adenocarcinoma, which may make that modest effect of genotypes on MDM4 expression is overwhelmed. This evidence concerns the gene MDM4 and adenosquamous carcinoma.